Navigation Links
Delayed access to tertiary care associated with higher death rate from type of pulmonary fibrosis
Date:7/1/2011

  • Patients with a form of pulmonary fibrosis often do not get referred to a tertiary care center quickly.

  • Delayed access is associated with a higher death rate.

  • Better methods of early detection would shorten time from first symptoms to referral.

(NEW YORK, NY, July 1, 2011) Idiopathic pulmonary fibrosis (IPF)―scarring and thickening of the lungs from unknown causes―is the predominant condition leading to lung transplantation nationwide. Columbia University Medical Center researchers confirmed that delayed access to a tertiary care center for IPF is associated with a higher risk of death. The findings were published online in the American Journal of Respiratory and Critical Care Medicine on June 30, 2011.

A group led by Columbia researcher David J. Lederer followed 129 IPF patients at an academic medical center. They looked at the length of time from the onset of shortness of breath to the first visit to the center. A longer delay was associated with increased risk of death, independent of age, gender, socioeconomic status, lung capacity, disease severity, type of health insurance, or education. The researchers also found no association between the length of delay and the likelihood of the patient's receiving a lung transplant.

IPF leads to respiratory failure and death, usually within three years. It is a relatively rare disease, which afflicts 100,000�,000 Americans, almost all over the age of 50. Characterized by shortness of breath upon exertion, it is often misdiagnosed, especially in people with other ailments.

A delay in making a correct diagnosis can lead to ineffective, or even harmful, treatments. For example, doctors sometimes still treat IPF with steroids, because the disease was originally thought to have an inflammatory component. Now scientists know that steroids are counterproductive. A delay in diagnosis can also delay evaluation for a lung transplant. Although research is underway on potential drug therapies, currently lung transplantation is the only effective treatment.

"The initial symptoms of IPF are subtle, and accurate diagnosis may not be feasible for community-based pulmonologists," explains Lederer, Herbert Irving Assistant Professor of Clinical Medicine and co-director of the New York-Presbyterian Hospital Interstitial Lung Disease Program and Lung Transplant Program.

For that reason, earlier access would be aided by improved methods of early detection. But until then, the recognition, or even suspicion, of IPF should prompt referral to a tertiary care center.


'/>"/>

Contact: Ann Rae Jonas
arj2116@columbia.edu
212-305-6535
Columbia University Medical Center
Source:Eurekalert

Related medicine news :

1. Taking Chemo Drug Continuously Delayed Lung Cancers Return
2. Common insecticide used in homes associated with delayed mental development of young children
3. Study shows delayed-enhancement MRI may predict, prevent strokes
4. Denosumab delayed time to first skeletal-related side effect
5. For HIV-positive patients, delayed treatment a costly decision
6. New study confirms positive effects of delayed school start times
7. $18.5 Million New Jersey Medical Malpractice Birth Injury Verdict Due To Cerebral Palsy Caused By A Delayed C-Section
8. Delayed retirement among Americans may bolster future of Social Security and Medicare, study finds
9. Pain Relief Often Delayed for Cancer Patients
10. Improving access to essential medicines through public-private partnerships
11. Clemson University research team to lead accessible voting technology project
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/25/2016)... , ... May 25, 2016 , ... ... has announced that it will join America's leading engineers at the American Society ... at the Georgia World Congress Center. , Engineers, speakers and exhibitors from ...
(Date:5/24/2016)... ... May 24, 2016 , ... BTC Media, a leading ... Distributed: Health, to be held in Nashville, Tennessee on September 7, 2016. , ... Hackathon preceding the event will host teams from around the world, competing to ...
(Date:5/24/2016)... Santa Rosa, California (PRWEB) , ... May 24, ... ... management (PHM) technology, debuted a new corporate identity and website at its “Transforming ... brand, website, and other marketing enhancements reflect i2i’s ongoing success to set the ...
(Date:5/24/2016)... ... May 24, 2016 , ... Local engineering ... Northern Virginia Medical Center located in Woodbridge, VA. The project includes a ... a single site. , The new 2 story building houses the Central Sterile ...
(Date:5/24/2016)... CA — , ... ... appointment of three new members of its Advisory Board. Joining ... and Sarah Kusch. “All three of them embody the mission of ... We are very fortunate to have them as we continue to ...
Breaking Medicine News(10 mins):
(Date:5/23/2016)... Gamida Cell, a leader in ... and orphan genetic diseases, announced today it has been ... the Israel Innovation Authority (formerly the Office of the ... Industry. The mission of the Israel Innovation Authority is ... science and technology, while stimulating economic growth. ...
(Date:5/22/2016)... , May 23, 2016 ... develop its anti-fibrotic and anti-inflammatory compound DS102 in ... as in non-alcoholic steatohepatitis (NASH) patients. ... significantly sequestered in lung tissue and has bronchodilatory, ... after oral administration. The Company will publish further ...
(Date:5/20/2016)... LONDON , May 20, 2016 ... for Therapeutic Antibody Technologies, Insulins, Growth Hormones, Recombinant ... Emerging Biological Drugs - This New Study Reveals ... Stay Ahead ,What is the ... get the latest technological and commercial analysis. Staying ...
Breaking Medicine Technology: